載入...
Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer
BACKGROUND: Despite improvement of tumour response rates in patients with progressive and metastatic cancer, immune checkpoint inhibitors (ICM) induce toxicities in cancer patients. Viscum album L. (VA, mistletoe) extracts are applied as add-on cancer therapy especially in German speaking countries...
Na minha lista:
| 發表在: | BMC Complement Altern Med |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5729272/ https://ncbi.nlm.nih.gov/pubmed/29237435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-017-2045-0 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|